{
    "title": "Breast cancer screening effect across breast density strata: A case-control study.",
    "doc_id": "27632020",
    "writer": "van der Waal D",
    "year": "2017",
    "summary": "Breast cancer screening is known to reduce breast cancer mortality. A high breast density may affect this reduction. ...Furthermore, a case-control study was performed for women having dense and women having fatty breasts. Breast density was ass â€¦",
    "abstract": "Breast cancer screening is known to reduce breast cancer mortality. A high breast density may affect this reduction. We assessed the effect of screening on breast cancer mortality in women with dense and fatty breasts separately. Analyses were performed within the Nijmegen (Dutch) screening programme (1975-2008), which invites women (aged 50-74 years) biennially. Performance measures were determined. Furthermore, a case-control study was performed for women having dense and women having fatty breasts. Breast density was assessed visually with a dichotomized Wolfe scale. Breast density data were available for cases. The prevalence of dense breasts among controls was estimated with age-specific rates from the general population. Sensitivity analyses were performed on these estimates. Screening performance was better in the fatty than in the dense group (sensitivity 75.7% vs 57.8%). The mortality reduction appeared to be smaller for women with dense breasts, with an odds ratio (OR) of 0.87 (95% CI 0.52-1.45) in the dense and 0.59 (95% CI 0.44-0.79) in the fatty group. We can conclude that high density results in lower screening performance and appears to be associated with a smaller mortality reduction. Breast density is thus a likely candidate for risk-stratified screening. More research is needed on the association between density and screening harms.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/27632020/"
}